Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

3D‑printed shape‑memory clear aligners for closing anterior open bite

Official title: Evaluating the Effectiveness of 3D Directly Printed Shape Memory Aligners in the Management of Anterior Open Bite

Run by Kufa University · NCT07420777 · Data updated 2026-11-12

This trial will test whether 3D‑printed shape‑memory clear aligners can help adults (18–35) with mild–moderate anterior open bite close their bite with or without attachments.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment51 (estimated)
SponsorKufa University
Academic / other
Locations1 site (Erbil, Erbil Governorate)
StatusRecruiting
StartedMay 1, 2026
Main results expectedDecember 26, 2026
Study endsMarch 27, 2027
Registry record updatedMay 11, 2026
Trial IDNCT07420777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18–35 with mild to moderate anterior dental open bite, fully erupted dentition, and well‑aligned or only mildly crowded teeth.

Probably not a fit

Patients with severe skeletal open bites, prior trauma or endodontic treatment on key teeth, systemic bone metabolism disorders, medications that affect tooth movement, or neuromuscular deficiencies are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized clinical trial will compare three treatments in adults with anterior dental open bite: conventional clear aligners with attachments, 3D direct‑printed shape‑memory aligners without attachments, and 3D direct‑printed shape‑memory aligners with attachments. Fifty‑one patients (17 per group) aged 18–35 with mild‑to‑moderate open bite will be recruited in Erbil, Iraq, and treated by a specialist orthodontist. Primary outcomes include changes in overbite, molar intrusion, anterior tooth extrusion, stress distribution, and initial tooth displacement measured clinically and with imaging/modeling over the treatment period. The trial is ethically approved, randomized, and powered to detect a 1.5 mm difference in overbite between groups.

Why it matters

Potential benefit: If successful, these aligners could provide a less invasive and potentially attachment‑free option to close anterior open bites.

How similar studies have gone: Conventional clear aligners with attachments have some clinical support for certain tooth movements and limited molar intrusion, but direct 3D‑printed shape‑memory aligners are largely novel with mainly laboratory or early‑stage data rather than established clinical success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-35 years,
2. Both genders.
3. The patient is well fitted with no systemic disease.
4. Mild-moderate dental anterior open bite.
5. Well-aligned or mildly crowded dentition.

Exclusion Criteria:

1. Patient with a history of trauma to the molars or incisors.
2. Patient with a history of endodontic treatment to the maxillary first molar or incisors.
3. Patient with a systemic disease related to bone metabolism.
4. Patient taking immunosuppressive drugs or drugs inhibiting or accelerating tooth movement; and
5. Patient with neuromuscular deficiencies.

Where it's running

  • Azadi dental center
    Erbil, Erbil Governorate, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.